Elevated Levels of Eotaxin-2 in Serum of Fibromyalgia Patients
FMS patients demonstrate an altered profile of chemokines relative to healthy controls (HC). Eotaxin-2 is a potent chemoattractant distributed in a variety of tissues. The aim of the study was to compare serum levels of eotaxin-2 between FMS patients and HC and to examine a potential correlation bet...
Saved in:
| Main Authors: | Victoria Furer, Eyal Hazan, Adi Mor, Michal Segal, Avi Katav, Valerie Aloush, Ori Elkayam, Jacob George, Jacob N. Ablin |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2018-01-01
|
| Series: | Pain Research and Management |
| Online Access: | http://dx.doi.org/10.1155/2018/7257681 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Fibromyalgia: are you a genetic/environmental disease?
by: Jacob N. Ablin
Published: (2025-06-01) -
Current and Emerging Pharmacotherapy for Fibromyalgia
by: Roie Tzadok, et al.
Published: (2020-01-01) -
Distinct Roles Between Eotaxin 1 and Eotaxin 2 in Asthmatic Airways
by: Soyoon Sim, et al.
Published: (2025-07-01) -
Effects of Workplace-Related Factors on the Prevalence of Fibromyalgia among Israeli Kindergarten Teachers
by: Yafa Buskila, et al.
Published: (2020-01-01) -
Targeted limbic self-neuromodulation for alleviating central sensitization symptoms in fibromyalgia
by: Ayelet Or-Borichev, et al.
Published: (2025-05-01)